= Emerging. More than 5 years before clinical availability. |
= Expected to be clinically available in 1 to 4 years. |
= Clinically available now. |
Topic: Practical Training
Authors: Catarina Horro Pita, Michael Wright
|
||
Short Abstract Poor solubility and non-specific binding can be insidious problems that are often overlooked during method development. These issues can result in costly and time-consuming batch failures during validation and, more importantly, the generation of inaccurate results during sample analysis. This training will describe in detail these issues, illustrate case studies and conclude with a workshop, where the audience will be asked to review ‘troublesome’ methods and suggest possible solutions. |
||
Long Abstract The solubility and non-specific binding of an analyte can be affected by the pH and composition of the solution / biological matrix, a common example being a well-behaved plasma assay that exhibits binding issues when transferred to urine. Non-specific binding may also be influenced by the type of material where the solution / biological sample is contained. In addition, both solubility and non specific binding can be affected by the sample extraction technique, sample storage duration and / or temperature. This session will look at these two phenomena and describe a range of possible solutions to overcome these issues. |
||
References & Acknowledgements:
|
Description | Y/N | Source |
Grants | no | |
Salary | no | |
Board Member | no | |
Stock | no | |
Expenses | no |
IP Royalty: no
Planning to mention or discuss specific products or technology of the company(ies) listed above: | no |